Christophe Boldron

Preparation and Study of New Poly‐8‐Hydroxyquinoline Chelators for an anti‐Alzheimer Strategy

Céline Deraeve, Christophe Boldron, Alexandrine Maraval et al. · Chemistry - A European Journal · 2007 · 125 citations

Pharmaceutical Science, Chemistry, Chemical Biology +18

New Approach for the Preparation of Efficient DNA Cleaving Agents:  Ditopic Copper−Platinum Complexes Based on 3-Clip-Phen and Cisplatin

Paul de Hoog, Christophe Boldron, Patrick Gámez et al. · Journal of Medicinal Chemistry · 2007 · 66 citations

Molecular Biology, Ditopic Copper−platinum Complexes, Double-stranded Fashion +19

DNA Cleavage by Copper Complexes of 2‐ and 3‐Clip‐Phen Derivatives

Marguerite Pitié, Christophe Boldron, Heinz Gornitzka et al. · European Journal of Inorganic Chemistry · 2003 · 60 citations

Inorganic Compound, Inorganic Chemistry, Nucleic Acid Chemistry +11

Copper‐Mediated Selective Oxidation of a CH Bond

Christophe Boldron, Patrick Gámez, D.M. Tooke et al. · Angewandte Chemie International Edition · 2005 · 56 citations · Full text

<i>N</i>-[6-(4-Butanoyl-5-methyl-1<i>H</i>-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1<i>H</i>-indole-3-carboxamide (SAR216471), a Novel Intravenous and Oral, Reversible, and Directly Acting P2Y12 Antagonist

Christophe Boldron, Angélina Besse, Marie-Françoise Bordes et al. · Journal of Medicinal Chemistry · 2014 · 49 citations · Full text

Acting P2y12 Antagonist, Immunology, Pharmacotherapy +22